Takeda Pharmaceutical Company Limited has selected Avella Specialty Pharmacy to distribute NINLARO, a new pharmaceutical drug that is used for treating patients with multiple myeloma. NINLARO is a FDA-approved oral proteasome inhibitor that blocks certain growth enzymes produced by cancerous cells. The drug is for use in combination with lenalidomide and dexamethasone. Read More »

The drug Envarsus XR will be available at transplant pharmacy BiologicTx Monday. "BiologicTx's primary focus and responsibility is to provide the transplant patient with the best possible products," Sal Rafanelli said. As a pharmacy that focuses on specialty areas, Biologic Tx is looking forward to having the drug. Envarsus helps transplant recipients suppress kidney rejections. Read More »

The Center for American Progress (CAP) recently submitted a proposal to improve Medicare by offering transparency in drug costs while reducing costs for consumers. Read More »

Omnicell will showcase its new and enhanced medication management solutions during this year's American Society of Health-System Pharmacists mid-year meeting next Monday through Thursday in New Orleans. Read More »

A.T. Kearney and the Outreach and Business Development Working Group of the National Association of Chain Drug Stores (NACDS) Retail Advisory Board (RAB) revealed their study Tuesday on the digital marketing campaigns of retailers, CPG manufacturers and pharmaceutical companies.  Read More »

A new study by pharmaceutical company Sanofi reveals that the majority of Americans are generally unaware of the dangers related to counterfeit medications -- a trend that causes up to 1 million deaths around the world each year. Read More »

Publix's pharmacies began offering free medications Tuesday as part of its free medication program. Read More »

The American College of Cardiology held a roundtable Oct. 24  to discuss health care issues and anticoagulation management. Read More »

Express Scripts partnered with Imprimis Pharmaceuticals Tuesday to provide a more affordable version of a life-saving drug known as Daraprim. Read More »

A federal court recently denied a motion from the state of Arkansas to dismiss a lawsuit brought by the Pharmaceutical Care Management Association (PCMA) that challenges the legality of Arkansas 900. Read More »

Bristol-Myers Squibb Foundation marked World AIDS Day Tuesday with $3.5 million in grants for HIV programs in Africa. Read More »

The pharmaceutical industry may soon be seeing a drastic change in its environmental protocol as recently highlighted by the International Pharmaceutical Federation (FIP). Read More »

Bristol-Myers Squibb's drug Empliciti was approved by the Food and Drug Administration (FDA) Monday as a combination treatment for multiple myeloma, a form of blood cancer. Read More »

TeaserCraneware, Inc., will present a new version of its Pharmacy ChargeLink at the American Society for Health-System Pharmacists 2015 Midyear Clinical Meeting. Read More »

Acadia Pharmaceuticals named Srdjan (Serge) Stankovic to serve as its executive vice president and head of research and development Monday. Read More »

The National Association of Chain Drug Stores (NACDS) Foundation launched the Comprehensive Motivational Interviewing Training for Health Care Professionals (comMlt) program Nov. 18.  Read More »

Walgreens began offering same-day prescription delivery Monday for customers at select Dallas stores through its new partnership with crowdsourced last-mile logistics company Deliv. Read More »

Mylan Laboratories Limited, a subsidiary of global pharmaceutical company Mylan, expanded its health care offerings for women on Nov. 20 by acquiring Famy Care Limited's female health care businesses known as Jai Pharma. Read More »

Eli Lilly and Co.'s drug Portrazza was approved by the Food and Drug Administration (FDA) Nov. 24 as a combination treatment for advanced squamous non-small cell lung cancer (NSCLC). Read More »

Biotechnology company Pieris Pharmaceuticals announced Monday that it received a milestone payment of an undisclosed amount from Sanofi for the continuous advancement of the tetraspecific Anticalin-based program for infectious disease. Read More »